Solving capital problems for pharmaceutical businesses with financial solutions from SeABank

In the context of the pharmaceutical industry increasingly focusing on investment in research, production and distribution activities, the need for stable and flexible capital sources has become a key factor for businesses to maintain growth momentum and improve competitiveness. In order to meet that need, SeABank has provided a solution for pharmaceutical business loans with many special offers. Let's find out about this financial solution with SeABank in the article below.

Current status of capital needs of industry enterprises medicine

The pharmaceutical industry is currently under great pressure due to strategic changes by the State, including: factories meeting WHO-GMP, EU-GMP standards, encouraging research on high-tech drugs, biological drugs, vaccines, etc. In particular, the national program to 2030, vision 2045 is also promoting the need for investment in production, R&D and technological innovation.

However, to meet these goals, most pharmaceutical enterprises in Vietnam still face many challenges:

• Production process depends on raw materials & imports increasingly.
• Pharmaceutical enterprises must invest heavily in R&D, testing, and equipment investment, but their liquidity sources mainly come from hospitals and pharmacies with long payment periods.
• Most pharmaceutical businesses are small and medium enterprises (SMEs), with limited financial capacity and few collateral assets.

Pharmaceutical enterprises in Vietnam are facing many challenges in terms of capital.

Understanding the above challenges, SeABank has developed a loan package for pharmaceutical and medical businesses with many separate preferential policies. In particular, the loan package supports flexible guarantees and credit, reducing pressure on fixed assets, helping businesses access capital more easily to invest in production, improve competitiveness and meet the development orientation of the pharmaceutical industry in the coming period.

When should pharmaceutical businesses borrow capital?

Pharmaceutical enterprises should choose SeABank's specialized loan package when they need additional capital for production and business activities. Especially when:

• When businesses sign contracts to import raw materials and produce according to orders (invoices, orders), they need capital right to deploy.
• Businesses need to import raw materials and medical equipment and need a letter of credit (L/C).
• Enterprises participating in bidding for hospitals or medical facilities need bid bonds (SeABank supports the issuance of bonds with high credit rates, helping enterprises not to worry about collateral).
• Enterprises with abundant assets (deposits, real estate, means of transport, current/future debt claims) and long-term R&D investment plans can take advantage of this to ensure favorable loans with suitable interest rates.

Businesses should prioritize borrowing capital when they need additional finance for production and business.

Loan solutions for businesses medicine with offers at SeABank

With outstanding growth potential, the pharmaceutical industry is facing many great opportunities but also many challenges in terms of capital. Understanding that, SeABank has launched a specialized loan financing solution package for pharmaceutical businesses to help optimize cash flow and expand effective access to credit.

Introducing pharmaceutical business loan package at SeABank

SeABank offers a solution package tailored to best meet the needs of businesses operating in the fields of manufacturing and trading pharmaceuticals, medical supplies and equipment. This is not just a regular loan, but also a commitment to accompany the sustainable development of the business, helping you confidently expand your scale, improve product quality and affirm your position in the market.

SeABank has been implementing a preferential loan package exclusively for pharmaceutical businesses.

Benefits of pharmaceutical business loan packages at SeABank

SeABank's loan package is built on a deep understanding of the pharmaceutical industry, bringing outstanding benefits, helping businesses optimize resources and achieve business goals. Outstanding benefits of the pharmaceutical business loan package at SeABank include:

• Attractive & flexible interest rates: The loan package applies preferential interest rates, flexible according to each term and loan plan, helping businesses proactively plan their finances and reduce pressure on capital costs.
• Issuance of credit guarantees up to 100%: Enterprises enjoy high credit rates when issuing guarantees, helping to improve bidding capacity without collateral.
• Preferential guarantee issuance fee: Fees related to issuing guarantees are applied at preferential rates, helping businesses save significantly on financial costs.
• Maximum support for application procedures: SeABank ensures to simplify processes, documents and certificates, helping businesses access capital quickly and conveniently.

Flexible collateral includes:

• Deposits at SeABank or other credit institutions.
• Real estate: For example, factories, land, offices, warehouses,...
• Means of transport: Specialized cars, trucks serving import and export of medical equipment.
• Debt collection rights: Contracts, invoices, debt collection rights from hospitals and medical facilities (including current and future debts).

Pharmaceutical business loan package at SeABank offers flexible financial solutions

Conclude

With flexible policies, simple procedures and many outstanding incentives, the package pharmaceutical business loans at SeABank is a practical financial solution, helping businesses proactively manage capital and develop sustainably.

To learn more and apply for pharmaceutical business loan solutions at SeABank, please visit the website: https://www.seabank.com.vn/doanh-nghiep or contact Hotline 1900.599.952 (KHDN).